Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action
This statistic shows the distribution of the immuno-oncology pipeline as of April 2018, by mechanism of action. At that moment, over 300 immunotherapies for cancer were in the pipeline of which 58 percent had PD-1/PD-L1 inhibitor/modulators as the mechanism of action.